Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2020
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapyAndrea Ferrari, Johannes H M Merks, Julia C Chisholm, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 25, 2021
Locally aggressive rarely metastazing tumors and low-grade sarcoma in children, adolescents and young adults: The benefits of a national networkClaire Brisset, Matthieu Carton, Claire Chemin-Airiau, et al.Cancer|April 21, 2023
Metastatic adult-type non-rhabdomyosarcoma soft tissue sarcomas in children and adolescents: A cohort study from the European paediatric Soft tissue sarcoma Study GroupAndrea Ferrari, Daniel Orbach, Michela Casanova, et al.Cancer Medicine|September 2, 2020
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 studySheila E J Terwisscha van Scheltinga, Marc H W A Wijnen, Hélène Martelli, et al.Cancer Discovery|March 16, 2022
The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent MalignanciesPablo Berlanga, Gaelle Pierron, Ludovic Lacroix, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trialSusanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II TrialJuliet C Gray, Rebekah Weston, Cormac Owens, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2024
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma TrialLucas Moreno, Rebekah Weston, Cormac Owens, et al.Pageof 4